Skip to main content

Humana Value Stock - Dividend - Research Selection

Humana

ISIN: US4448591028 , WKN: 856584

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group and Specialty segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment provides pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. The Individual Commercial segment offers individual commercial fully-insured medical health insurance benefits under the HumanaOne brand. The company also provides closed-block long-term care insurance policies. As of December 31, 2017, it had approximately 14 million members in medical benefit plans, as well as approximately 7 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


EYEBUYDIRECT CELEBRATES 20 YEARS IN BUSINESS AND 30 MILLION PAIRS SOLD - AND COUNTING

2026-06-15
Eyebuydirect, a leading online destination for high-quality, affordable prescription eyewear, is celebrating 20 years of helping people see clearly and express their personal style. Since launching in 2006 with a catalog of just 100 frame styles, the brand has grown into a global eyewear destination that has sold more than 30 million pairs of glasses and served over 8 million customers across 40 countries.

Jim Cramer on UnitedHealth: “Buy It”

2026-06-15
UnitedHealth Group Incorporated (NYSE:UNH) was among the stocks Jim Cramer highlighted during Mad Money, as he noted the rotation into defensive sectors. Cramer called the company’s CEO “legendary,” as he commented: Finally, we have UnitedHealth. It’s another managed care play that’s up for the same reason as Humana. The stock pulled back this afternoon, but […]

Jim Cramer on Humana: “This Is a Textbook Safety Stock”

2026-06-15
Humana Inc. (NYSE:HUM) was among the stocks Jim Cramer highlighted during Mad Money, as he noted the rotation into defensive sectors. Cramer highlighted an “unexpected gift” for the company, as he remarked: Then back to defense, Humana, the giant health insurer, got a… huge break from the Trump administration not that long ago when it […]

JPMorgan and Mizuho Raise Humana (HUM) Price Targets as Managed Care Outlook Improves

2026-06-15
Humana Inc. (NYSE:HUM) is included among Billionaire Larry Robbins’ 10 Dividend Stock Picks. On June 8, JPMorgan analyst Lisa Gill raised the firm’s price target on Humana Inc. (NYSE:HUM) to $316 from $214 and maintained a Neutral rating on the shares. The firm updated its healthcare services models. The same day, Mizuho raised its price […]

Mizuho Raises its Price Target on Humana (HUM)

2026-06-13
Humana Inc. (NYSE:HUM) is one of the 7 Best Turnaround Stocks to Buy in 2026. On June 8, 2026, Mizuho raised the firm’s price target on Humana Inc. (NYSE:HUM) to $390 from $335 and maintained an Outperform rating on the shares. The firm said the managed care sector is entering a “more stable and predictable” […]

Humana Reshapes Care Exposure With Gentiva Exit And Illinois Medicaid Win

2026-06-12
Humana (NYSE:HUM) agreed to sell its minority stake in Gentiva for approximately US$900 million, exiting equity ownership in home health, palliative, and hospice care. The insurer was also selected as a winner in Illinois' Medicaid managed care program, adding a new state contract to its government focused portfolio. For a company centered on Medicare Advantage and other government backed insurance, these moves represent a meaningful repositioning of how Humana (NYSE:HUM) is exposed to care...

Humana Closes the Kindred Chapter With $900 Million Gentiva Exit

2026-06-11
HUM is cashing out its Gentiva stake for $900 million, completing a multiyear effort to sharpen focus on its core health insurance business.

Evercore ISI Group Maintains In-Line on Humana, Raises Price Target to $370

2026-06-11
Evercore ISI Group analyst Elizabeth Suzuki maintains Humana (NYSE:HUM) with a In-Line and raises the price target from $250 to $370.

Humana divests interest in end-of-life provider Gentiva valued at $900M

2026-06-11
The insurer is offloading its interest in the massive end-of-life care provider to an undisclosed group of investors, amid widespread concern about private investors’ activity in healthcare.

Patients Denied Care, Then Approved Later? Federal Watchdog Raises Medicare Advantage Concerns

2026-06-11
Federal investigators found Medicare Advantage plans frequently denied requests for nursing and rehabilitation care, with many decisions later overturned on appeal.